• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证食管癌放疗相关食管瘘的风险预测模型。

Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer.

机构信息

School of Medicine, Shandong University, Jinan, China.

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No.440, Ji Yan Road, Jinan, Shandong, 250012, People's Republic of China.

出版信息

Radiat Oncol. 2019 Oct 22;14(1):181. doi: 10.1186/s13014-019-1385-y.

DOI:10.1186/s13014-019-1385-y
PMID:31640802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6805370/
Abstract

OBJECTIVES

We aimed to identify the risk factors and provide a nomogram for the prediction of radiotherapy-related esophageal fistula in patients with esophageal cancer (EC) using a case-control study.

PATIENTS AND METHODS

Patients with esophageal fistula who received radiotherapy or chemoradiotherapy between 2003 and 2017 were retrospectively collected in two institutions. In the training cohort (TC), clinical, pathologic, and serum data of 136 patients (cases) who developed esophageal fistula during or after radiotherapy were enrolled and compared with 272 controls (1:2 matched with the diagnosis time of EC, sex, marriage, and race). After the univariable and multivariable logistic regression analyses, the independent risk factors were identified and incorporated into a nomogram. Then the nomogram for the risk prediction was externally validated in the validation cohort (VC; 47 cases and 94 controls) using bootstrap resampling.

RESULTS

Multivariable analyses demonstrated that ECOG PS, BMI, T4, N2/3 and re-radiotherapy were independent factors for esophageal fistula. Then a nomogram was constructed with the C-index of 0.805 (95% CI, 0.762-0.848) for predicting the risk of developing esophageal fistula in EC patients receiving radiotherapy. Importantly, the C-index maintained 0.764 (95% CI, 0.683-0.845) after the external validation.

CONCLUSIONS

We created and externally validated the first risk nomogram of esophageal fistula associated with radiotherapy. This will aid individual risk stratification of patients with EC developing esophageal fistula.

摘要

目的

本研究旨在通过病例对照研究,确定食管癌(EC)患者接受放疗后发生放射性食管瘘的危险因素,并建立预测模型。

方法

回顾性收集 2003 年至 2017 年间在两家机构接受放疗或放化疗的食管瘘患者。在训练队列(TC)中,纳入了 136 例(病例)放疗或放化疗期间或之后发生食管瘘的患者的临床、病理和血清数据,并与 272 例(1:2 配对)EC 诊断时间、性别、婚姻状况和种族匹配的对照进行比较。在单变量和多变量逻辑回归分析后,确定独立的危险因素,并将其纳入列线图。然后,通过bootstrap 重抽样法在验证队列(VC;47 例病例和 94 例对照)中对预测模型进行外部验证。

结果

多变量分析表明,ECOG PS、BMI、T4、N2/3 和再放疗是食管瘘的独立危险因素。然后,构建了一个预测接受放疗的 EC 患者发生食管瘘风险的列线图,其 C 指数为 0.805(95%CI,0.762-0.848)。重要的是,外部验证后 C 指数仍保持在 0.764(95%CI,0.683-0.845)。

结论

我们建立并外部验证了首个与放疗相关的食管瘘风险列线图,这将有助于对发生食管瘘风险的 EC 患者进行个体风险分层。

相似文献

1
Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer.开发和验证食管癌放疗相关食管瘘的风险预测模型。
Radiat Oncol. 2019 Oct 22;14(1):181. doi: 10.1186/s13014-019-1385-y.
2
Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.基于影像组学和临床因素的恶性食管瘘预后列线图的建立和验证。
Thorac Cancer. 2021 Dec;12(23):3110-3120. doi: 10.1111/1759-7714.14115. Epub 2021 Oct 14.
3
Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.食管鳞状细胞癌患者新辅助放化疗后病理完全缓解预测列线图的开发
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12519.
4
Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram.基于放射组学-临床列线图预测食管癌恶性食管瘘
Eur J Med Res. 2024 Apr 4;29(1):217. doi: 10.1186/s40001-024-01746-2.
5
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram.预测食管癌放化疗期间严重淋巴细胞减少症:预处理列线图的建立与验证。
Pract Radiat Oncol. 2020 Jan-Feb;10(1):e16-e26. doi: 10.1016/j.prro.2019.07.010. Epub 2019 Jul 29.
6
Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.基于放射组学的模型预测食管鳞癌放化疗后局部无进展生存期的建立和验证
Radiat Oncol. 2021 Oct 12;16(1):201. doi: 10.1186/s13014-021-01925-z.
7
Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy.分析化放疗治疗 T4 期食管癌患者瘘的形成。
Esophagus. 2020 Jan;17(1):67-73. doi: 10.1007/s10388-019-00691-y. Epub 2019 Sep 10.
8
A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients.预测食管癌患者放疗相关食管瘘风险的列线图
Front Oncol. 2022 Jan 18;11:785850. doi: 10.3389/fonc.2021.785850. eCollection 2021.
9
Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.列线图预测食管癌三联治疗后生存的验证。
Ann Thorac Surg. 2018 Nov;106(5):1541-1547. doi: 10.1016/j.athoracsur.2018.05.055. Epub 2018 Jun 19.
10
[Establishment of a nomogram predicting risk factors of postoperative perineal wound complications after abdominoperineal resection for rectal cancer].[建立预测直肠癌腹会阴联合切除术后会阴伤口并发症危险因素的列线图]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):357-363. doi: 10.3760/cma.j.issn.1671-0274.2019.04.008.

引用本文的文献

1
Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma.食管鳞状细胞癌一线免疫治疗联合放化疗的真实世界研究
Sci Rep. 2025 Aug 4;15(1):28343. doi: 10.1038/s41598-025-12250-w.
2
Prediction of esophageal fistula in radiotherapy/chemoradiotherapy for patients with advanced esophageal cancer by a clinical-deep learning radiomics model : Prediction of esophageal fistula in radiotherapy/chemoradiotherapy patients.临床深度学习放射组学模型预测晚期食管癌放化疗后食管瘘:放化疗患者食管瘘预测。
BMC Med Imaging. 2024 Nov 18;24(1):313. doi: 10.1186/s12880-024-01473-4.
3

本文引用的文献

1
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.泛亚地区改编的 ESMO 临床实践指南:管理转移性食管癌患者:由 JSMO-ESMO 发起,得到 CSCO、KSMO、MOS、SSO 和 TOS 的支持。
Ann Oncol. 2019 Jan 1;30(1):34-43. doi: 10.1093/annonc/mdy498.
2
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.根治性放化疗治疗侵犯邻近器官的胸段食管鳞癌并发食管瘘的危险因素:一项单中心病例对照研究。
BMC Cancer. 2018 May 18;18(1):573. doi: 10.1186/s12885-018-4486-3.
3
Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy.
不可切除食管鳞癌放疗后食管呼吸瘘的预后因素。
Sci Rep. 2024 Jul 26;14(1):17144. doi: 10.1038/s41598-024-67859-0.
4
Clinical-radiomics nomogram for the risk prediction of esophageal fistula in patients with esophageal squamous cell carcinoma treated with intensity-modulated radiation therapy or volumetric-modulated arc therapy.用于预测接受调强放射治疗或容积调强弧形治疗的食管鳞状细胞癌患者食管瘘风险的临床-放射组学列线图。
J Thorac Dis. 2024 Mar 29;16(3):2032-2048. doi: 10.21037/jtd-24-191. Epub 2024 Mar 20.
5
Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram.基于放射组学-临床列线图预测食管癌恶性食管瘘
Eur J Med Res. 2024 Apr 4;29(1):217. doi: 10.1186/s40001-024-01746-2.
6
Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapy.多组学和多感兴趣区域用于预测接受放疗的食管癌患者的食管瘘
J Cancer Res Clin Oncol. 2024 Jan 27;150(2):39. doi: 10.1007/s00432-023-05520-5.
7
Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma.免疫检查点抑制剂联合或不联合放(化)疗用于局部晚期或复发/转移性食管鳞状细胞癌
Discov Oncol. 2023 Sep 4;14(1):165. doi: 10.1007/s12672-023-00783-3.
8
Deep multimodal fusion of image and non-image data in disease diagnosis and prognosis: a review.疾病诊断与预后中图像和非图像数据的深度多模态融合:综述
Prog Biomed Eng (Bristol). 2023 Apr 11;5(2). doi: 10.1088/2516-1091/acc2fe.
9
The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume-Center.年龄和合并症在老年体弱(>70岁)食管癌和胃癌放化疗中的作用:来自大型三级中心的分析
Cancers (Basel). 2022 Dec 23;15(1):106. doi: 10.3390/cancers15010106.
10
Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy.采用 CT 定量分析预测接受化疗或放化疗的晚期食管癌患者发生食管瘘的风险。
Cancer Imaging. 2022 Nov 4;22(1):62. doi: 10.1186/s40644-022-00490-2.
Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy.
接受放化疗的局部晚期食管癌患者发生食管瘘的危险因素。
Onco Targets Ther. 2018 Apr 23;11:2311-2317. doi: 10.2147/OTT.S161803. eCollection 2018.
4
Logistic regression analysis of the risk factors of anastomotic fistula after radical resection of esophageal-cardiac cancer.Logistic 回归分析食管贲门癌根治术后吻合口瘘的危险因素。
Thorac Cancer. 2017 Nov;8(6):666-671. doi: 10.1111/1759-7714.12509. Epub 2017 Sep 20.
5
Placement of transnasal drainage catheter and covered esophageal stent for the treatment of perforated esophageal carcinoma with mediastinal abscess.经鼻引流导管及带膜食管支架置入术治疗食管癌穿孔并纵隔脓肿
J Surg Oncol. 2016 Nov;114(6):725-730. doi: 10.1002/jso.24384. Epub 2016 Sep 22.
6
High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma.单纯大剂量放疗联合适度低分割放疗用于胸段食管鳞状细胞癌患者
Medicine (Baltimore). 2016 Aug;95(33):e4591. doi: 10.1097/MD.0000000000004591.
7
A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma.不可切除食管鳞状细胞癌患者中紫杉烷与氟尿嘧啶为基础的放化疗的回顾性比较
J Cancer. 2016 May 25;7(9):1066-73. doi: 10.7150/jca.13547. eCollection 2016.
8
Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.局部晚期不可切除食管癌同步放化疗相关食管瘘的危险因素:JCOG0303补充分析
Medicine (Baltimore). 2016 May;95(20):e3699. doi: 10.1097/MD.0000000000003699.
9
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
10
A retrospective study of californium-252 neutron brachytherapy combined with EBRT versus 3D-CRT in the treatment of esophageal squamous cell cancer.一项关于锎 - 252 中子近距离放射治疗联合外照射放疗与三维适形放疗治疗食管鳞状细胞癌的回顾性研究。
Radiat Oncol. 2015 Oct 24;10:212. doi: 10.1186/s13014-015-0520-7.